Daily MedNews
Printable Version   Email to a friend

Clinical Trials Update: Aug. 21, 2008

-- Here are the latest clinical trials, courtesy of CenterWatch:

Sleep Disorders

If you are aged 18 to 65, in good general health, and wake up multiple times during a typical night, you may qualify for this study.

The research site is in Las Vegas, Nev.

More information

Please see http://www.centerwatch.com/patient/studies/cat169.html.

-----

Urticaria

If your child is 6 months to 11 months, has symptoms of allergic rhinitis, and is taking antihistamines or is a candidate for such treatment, the child may qualify for this study.

The research site is in Jonesboro, Ark.

More information

Please see http://www.centerwatch.com/patient/studies/cat811.html.

-----

Coronary Artery Disease

If you are at least 45, were recently hospitalized for acute coronary syndrome, and are clinically stable, you may qualify for this study.

The research site is located in Taunton, Mass.

More information

Please see http://www.centerwatch.com/patient/studies/cat50.html.

-----

Copyright 2008 CenterWatch. All rights reserved.


Latest Daily MedNews...

Daily MedNews Archive

2008: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2007: Jul | Aug | Sep | Oct | Nov | Dec

More News Resources


MedNotes
Latest FDA Drug Alerts
December 2, 2008
Audience: Hematological and Nephrological healthcare professionals, hospital risk managers [Posted 12/02/2008] FDA has received...
December 2, 2008
Audience: Oncologists, other healthcare professionals[UPDATE 12/02/2008] FDA issued Q&As for recently approved Medication...
November 26, 2008
Audience: Consumers, healthcare professionals [Posted 11/26/2008] Balanced Health Products, Inc. announced a recall of STARCAPS...
November 26, 2008
Audience: Consumers, healthcare professionals [Posted 11/26/2008] Fashion Sanctuary announced a recall of Zhen De Shou Fat Loss...
More...
Latest Drug Information Updates

Promacta
Promacta (eltrombopag) is a thrombopoietin receptor agonist indicated for the treatment of thrombocytopenia in patients with chronic immune (idiopathic) thrombocytopenic purpura.

Banzel
Banzel (rufinamide) is a triazole derivative antiepileptic drug for the adjunctive treatment of seizures associated with Lennox-Gastaut syndrome.

Apriso
Apriso (mesalamine) is a once-daily, locally-acting aminosalicylate indicated for the maintenance of remission of ulcerative colitis (UC) in adults.

LoSeasonique
LoSeasonique is a lower-dose, extended-cycle oral contraceptive indicated for the prevention of pregnancy.

Acanya
Acanya (benzoyl peroxide and clindamycin phosphate) is a topical antibacterial and antibiotic combination for the treatment of acne.

Toviaz
Toviaz (fesoterodine fumarate) is a competitive muscarinic receptor antagonist indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency.

Vimpat
Vimpat (lacosamide) is an anti-convulsant drug for the treatment of partial onset seizures in adults with epilepsy.

Astepro
Astepro (azelastine) is a nasal antihistamine for the treatment of seasonal allergic rhinitis.

Rapaflo
Rapaflo (silodosin) is an alpha(1)- adrenoreceptor antagonist for the treatment of the signs and symptoms associated with benign prostatic hyperplasia (BPH), or enlarged prostate.

Cinryze
Cinryze is a C1-esterase inhibitor indicated for routine prophylaxis against angioedema attacks in adolescent and adult patients with Hereditary Angioedema (HAE).

Akten
Akten (lidocaine hydrochloride) Ophthalmic Gel is a topical, ocular anesthetic formulation for use in ocular procedures that require a topical anesthetic agent.

AdreView
AdreView is a diagnostic radiopharmaceutical agent indicated for use in the detection of rare neuroendocrine tumors in children and adults.

Sancuso
Sancuso (granisetron transdermal system) is an anti-emetic transdermal delivery system indicated for the control of nausea and vomiting in patients receiving moderately and/or highly nausea-inducing chemotherapy.

Nplate
Nplate (romiplostim) is a thrombopoietin mimetic peptibody for the treatment of thrombocytopenia in adult patients with chronic immune (idiopathic) thrombocytopenic purpura (ITP).

Xenazine
Xenazine (tetrabenazine) is a selective and reversible centrally-acting dopamine depleting drug indicated for the treatment of chorea associated with Huntington's disease.

More...